Back to Search
VAN CHRISTIANSEN, MD
MD
Family Medicine Physician
NPI: 1093702672IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Class of 1991
Research & Publications (12)
Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.
PMID 19402713·Biochemistry·2009
8-other
Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.
PMID 18564219·J Thromb Haemost·2008
8-other
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer.
PMID 18032930·Cancer Biol Ther·2007
3-trial
Why alpha-antiplasmin must be converted to a derivative form for optimal function.
PMID 17883704·J Thromb Haemost·2007
8-other
The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity.
PMID 17317851·Blood·2007
8-other
Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.
PMID 17174263·Arch Biochem Biophys·2007
7-preclinical
Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein.
PMID 16223769·Blood·2006
8-other
Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal.
PMID 15320781·Curr Med Chem Cardiovasc Hematol Agents·2004
6-review
A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.
PMID 14751930·Blood·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 W 2700 N
PLEASANT VIEW, UT 84404 - Phone
- (801) 475-3600
Quick Facts
- NPI
- 1093702672
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 12
Are you this provider?
Claim Your Profile